Focus on epithelial ovarian cancer.
Ozols
Robert F
RF
Fox Chase Cancer Center, Philadelphia, PA 19111, USA. robert.ozols@fccc.edu
Bookman
Michael A
MA
Connolly
Denise C
DC
Daly
Mary B
MB
Godwin
Andrew K
AK
Schilder
Russell J
RJ
Xu
Xiangxi
X
Hamilton
Thomas C
TC
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology; D001485:Basement Membrane / Q000378:metabolism* / Q000503:physiopathology; D002273:Carcinogens / Q000378:metabolism; D004195:Disease Models, Animal; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000378:metabolism; D005260:Female; D019398:Genes, BRCA1 / Q000502:physiology; D024522:Genes, BRCA2 / Q000502:physiology; D016147:Genes, Tumor Suppressor / Q000502:physiology; D015316:Genetic Therapy; D006062:Gonadotropins / Q000378:metabolism*; D006801:Humans; D051379:Mice; D009374:Neoplasms, Experimental / Q000503:physiopathology; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy / Q000503:physiopathology*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000378:metabolism
D000970:Antineoplastic Agents; D002273:Carcinogens; D006062:Gonadotropins; D042461:Vascular Endothelial Growth Factor A; D066246:ErbB Receptors